Literature DB >> 12516887

Understanding the physiology and pharmacology of epidural and intrathecal opioids.

Christopher M Bernards1.   

Abstract

Epidural and intrathecal opioid administration has become an important part of contemporary medical practice in a variety of clinical settings. It has been widely assumed that any opioid placed in the epidural or intrathecal spaces will produce highly selective spinally mediated analgesia that is superior to that produced by other analgesic techniques. Unfortunately, this is simply not true. In fact, multiple opioids are currently employed for spinal use despite the fact that clinical evidence has shown that spinal administration does not produce analgesia with a selective spinal mechanism or that the analgesia produced is not superior to that produced by intravenous administration. This chapter presents the basic science and clinical data available to assist clinicians in identifying which opioids are appropriate for spinal use and which are not.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516887     DOI: 10.1053/bean.2002.0255

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  12 in total

Review 1.  Intrathecal therapy for chronic pain: current trends and future needs.

Authors:  Salim M Hayek; Michael C Hanes
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 2.  Analysis of Multiple Routes of Analgesic Administration in the Immediate Postoperative Period: a 10-Year Experience.

Authors:  Nalini Vadivelu; Alice M Kai; Feng Dai; Susan Dabu-Bondoc
Journal:  Curr Pain Headache Rep       Date:  2019-03-11

Review 3.  [Pain therapy in intensive care patients].

Authors:  Katharina Rose; Winfried Meißner
Journal:  Anaesthesist       Date:  2018-06       Impact factor: 1.041

Review 4.  Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia.

Authors:  Stephan A Schug; David Saunders; Irina Kurowski; Michael J Paech
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

6.  Survey of pain specialists regarding conversion of high-dose intravenous to neuraxial opioids.

Authors:  Andrew W Gorlin; David M Rosenfeld; Jillian Maloney; Christopher S Wie; Johnathan McGarvey; Terrence L Trentman
Journal:  J Pain Res       Date:  2016-09-21       Impact factor: 3.133

7.  Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.

Authors:  Tony L Yaksh; Annelies de Kater; Robin Dean; Brookie M Best; George P Miljanich
Journal:  Neuromodulation       Date:  2012-07-02

8.  A clinical approach to neuraxial morphine for the treatment of postoperative pain.

Authors:  Borja Mugabure Bujedo
Journal:  Pain Res Treat       Date:  2012-07-02

Review 9.  Current evidence for spinal opioid selection in postoperative pain.

Authors:  Borja Mugabure Bujedo
Journal:  Korean J Pain       Date:  2014-06-30

10.  Neuroprotective effect of local hypothermia in a computer-controlled compression model in minipig: Correlation of tissue sparing along the rostro-caudal axis with neurological outcome.

Authors:  Stefania Gedrova; Jan Galik; Martin Marsala; Monika Zavodska; Jaroslav Pavel; Igor Sulla; Miroslav Gajdos; Imrich Lukac; Jozef Kafka; Valent Ledecky; Igor Sulla; Martina Karasova; Peter Reichel; Alexandra Trbolova; Igor Capik; Viktoria Lukacova; Katarina Bimbova; Maria Bacova; Andrea Stropkovska; Nadezda Lukacova
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.